newsfilter
← Latest News
ACCESS Newswire·

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment

- Dr. Reid Bissonnette, Executive Consultant for Translational Research and Development at Xenetic, discusses positive preclinical data recently presented at the Society for Immunotherapy of Cancer Spring